Join the Class Action Against ESSA Pharma Inc.
The Gross Law Firm is currently inviting shareholders of ESSA Pharma Inc. (NASDAQ: EPIX) to join a pending class action. If you acquired shares during the specified class period, you may have the rights to partake in a potential recovery.
Class Action Details
Shareholders who purchased shares of EPIX between December 12, 2023 and October 31, 2024, are encouraged to reach out to the Gross Law Firm. This is an opportunity to possibly be appointed as a lead plaintiff in this case, although participating in the class action does not require such an appointment.
Understanding the Allegations
The allegations in the complaint assert that the defendants made misleading statements regarding the efficacy of masofaniten when combined with enzalutamide for treating prostate cancer. Specifically, it claims:
- The combination therapy did not provide the expected benefits over enzalutamide alone.
- The study aimed at evaluating this combination therapy was unlikely to achieve its primary endpoint.
- Defendants misrepresented the potential of masofaniten regarding its clinical and commercial viability.
- As a result, their public statements were misleading at every significant point in time.
Important Deadline
Mark your calendars, as March 25, 2025, is the critical deadline for shareholders to register for this class action. Delaying could mean losing your chance for recovery. To register, visit the Gross Law Firm's official page for your information submission.
Next Steps for Shareholders
Upon registering, you will be enrolled in a portfolio monitoring software that provides updates about the progress of your case. The Gross Law Firm makes it known there is no cost or obligation to you for participation in this case.
Why Choose The Gross Law Firm?
The Gross Law Firm has built a reputation as a nationally recognized entity focused on protecting the rights of investors who have encountered deceit and fraudulent practices. Their commitment lies in ensuring that firms uphold honest business practices. With a proactive approach towards corporate transparency, Gross Law Firm seeks redress for investors who have faced losses due to misleading corporate actions. Remember, prior results do not ensure similar outcomes.
Contact Information
If you have any inquiries regarding the class action or wish to register, please reach out:
The Gross Law Firm
15 West 38th Street, 12th floor New York, NY 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is a class action lawsuit?
A class action lawsuit allows a group of people with similar claims against a company to sue collectively, making it easier and more efficient for justice to be sought.
What does it mean to be a lead plaintiff?
A lead plaintiff is a member of the class who acts on behalf of all class members. Being appointed as a lead plaintiff can enable someone to take a more active role in the litigation process.
What costs are associated with joining the class action?
Joining the class action with the Gross Law Firm incurs no fees. There is no financial obligation to participate.
How can I register for the class action?
Shareholders can register by submitting their information through the Gross Law Firm’s designated portal.
Is there a deadline for joining the class action?
Yes, the final date to register is March 25, 2025, so it is essential to act quickly.
